| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | 2-[(E)-[1-(2-Amino-1,3-thiazol-4-yl)-2-[[(2S,3S)-2-methyl-4-oxo-1-sulfoazetidin-3-yl]amino]-2-oxoethylidene]amino]oxy-2-methylpropanoic acid;(2S)-2,6-diaminohexanoic acid | FAERS: 20 | US FAERS | |
| 2 | tofacitinib | FAERS: 10 | US FAERS | |
| 3 | ivacaftor | FAERS: 5 | US FAERS | |
| 4 | Teriparatide | FAERS: 4 | US FAERS | |
| 5 | ambrisentan | FAERS: 4 | US FAERS | |
| 6 | Baclofen | FAERS: 3 | US FAERS | |
| 7 | Sorafenib | FAERS: 3 | US FAERS | |
| 8 | 4-hydroxybutyric acid | FAERS: 2 | US FAERS | |
| 9 | Norgestrel | FAERS: 2 | US FAERS | |
| 10 | PCI 32765 | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 11 | apremilast | FAERS: 2 | US FAERS | |
| 12 | baricitinib | FAERS: 2 | US FAERS | |
| 13 | 4-Aminopyridine | FAERS: 1 | US FAERS | |
| 14 | Afatinib | FAERS: 1 | US FAERS | |
| 15 | Canagliflozin | FAERS: 1 | US FAERS | |
| 16 | Dabigatran | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 17 | Dimethyl Fumarate | FAERS: 1 | US FAERS | |
| 18 | Epoprostenol | FAERS: 1 | US FAERS | |
| 19 | Erythromycin | FAERS: 1 | US FAERS | |
| 20 | Fluticasone | FAERS: 1 | US FAERS | |
| 21 | Methotrexate | FAERS: 1 | US FAERS | |
| 22 | Metoprolol | FAERS: 1 | US FAERS | |
| 23 | NuvaRing | FAERS: 1 | US FAERS | |
| 24 | Paroxetine | FAERS: 1 | US FAERS | |
| 25 | Temozolomide | FAERS: 1 | US FAERS | |
| 26 | Tobramycin | FAERS: 1 | US FAERS | |
| 27 | carfilzomib | FAERS: 1 | US FAERS | |
| 28 | ceftolozane, tazobactam drug combination | FAERS: 1 | US FAERS | |
| 29 | treprostinil | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.